跳至主要内容
临床试验/IRCT20180119038433N4
IRCT20180119038433N4尚未招募3 期

Investigation of effectiveness of sake yeast supplementation (Saccharomyces cerevisiae) and S-sdenosyl methionine (SAM) in pharmacoresistant epileptic patients

Semnan University of Medical Sciences0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Pharmacoresistant epileptic patients
  • Patients who have not responded to any of the anticonvulsant drugs on the market for at least one year

排除标准

  • Cancelation
  • Uncontrolled blood pressure
  • History of alcoholism or drug abuse,
  • Unreliable clinical records
  • Patients who does not take medication
  • Patients who does not attend the clinic orderly

研究者

发起方
Semnan University of Medical Sciences

相似试验